Phillip D Greenberg

25PUBLICATIONS
119CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 14, 2026
The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction.

Hongcheng Cheng, Yapeng Su, Xiaoli Pan

|Jan 03, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands.

Shihong Zhang, Tzu-Hao Tang, Sinéad Kinsella

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Sep 23, 2025
A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy.

Yapeng Su, Ashley Thelen, Lena V Wirth

|Sep 22, 2025
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Gabriel F Alencar, Asmaa O Mohamed, Madison G Burnett

|Mar 31, 2025
Hallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy.

Carolyn Shasha, David R Glass, Ernest Moelhman

Pageof 5

Frequent Collaborators

11 joint publications

Robert D Schreiber

9 joint publications

Keith T Flaherty

9 joint publications

Kenneth C Anderson

9 joint publications

Raymond N DuBois